jueves, 8 de octubre de 2020

Opposing Trial Results on CDK Inhibitors Means Good Science

Opposing Trial Results on CDK Inhibitors Means Good Science

Medscape Logo

CDK4/6 Inhibitors in Early Breast Cancer: Different Trial Results Means Good Science

Kathy D. Miller, MD
DISCLOSURES 
October 07, 2020

No hay comentarios:

Publicar un comentario